Meet the CEOs Webcast Replay

This week join the CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects.

  • Graham Kelly, from Noxopharm (ASX: NXO)
  • Max Bluvband, from AppsVillage (ASX: APV)

Recorded on 8th July 2020 at 12pm (AEST).

Join the next Meet the CEOs webcast

Speak to the Reach Markets team

FEATURE SPEAKERS

GRAHAM KELLY

Executive Chairman and CEO

Noxopharm (ASX: NXO) is an Australian-based, clinical stage drug development company which focuses on two areas of drug technology. The first is the potential benefit to cancer patients in being able to increase their responsiveness to standard of care chemotherapies and radiotherapies. Veyonda is the first pipeline drug candidate, with later generation drug candidates under investigation in an R&D program. The second area relates to the technology behind Veyonda and the opportunity it offers to exploit the broader therapeutic opportunities of isoflavonoid compounds.

MAX BLUVBAND

Chief Executive Officer

AppsVillage (ASX: APV) provides an easy and inexpensive SAAS solution that allows small-to-medium businesses to create and manage their own mobile application as a means of connecting with their customers and growing their business. AppsVillage’s technology has automated the design, development, maintenance and marketing of mobile apps, allowing any business to build, preview and launch their own application without having any writing or digital marketing knowledge.

latest other webcasts

Felix Gold (ASX: FXG) Webcast Replay June

Plutonic Investor Briefing

Q&A on Plutonic with Hedley Widdup

Speak to the Reach Markets team




What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.